Article Text

Download PDFPDF
Fifteen-minute consultation: enterovirus meningitis and encephalitis—when can we stop the antibiotics?
  1. Simon B Drysdale1,2,
  2. Dominic F Kelly1,2
  1. 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
  2. 2NIHR Oxford Biomedical Research Centre, Level 2, Children's Hospital, Oxford, UK
  1. Correspondence to Dr Simon B Drysdale, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, OX3 9DU, UK; simon.drysdale{at}paediatrics.ox.ac.uk

Abstract

Enterovirus (EV) is the most common cause of aseptic meningitis and has a benign course, unlike EV encephalitis, which can result in long-term neurological sequelae. There are no active treatments or prophylactic agents, and management is purely supportive. Obtaining an EV-positive cerebrospinal fluid result usually allows antimicrobial treatment to be stopped. This review will answer some of the common questions surrounding EV meningitis/encephalitis.

  • Enterovirus
  • parechovirus
  • meningitis
  • encephalitis
  • CSF

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SBD conceived the article. SBD wrote the original draft. SBD and DFK reviewed and redrafted it and approved the final version.

  • Competing interests DFK has received financial assistance from vaccine manufacturers to attend conferences and receives salary support from the NIHR Oxford Biomedical Research Centre.

  • Provenance and peer review Commissioned; internally peer reviewed.